XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.18

-5.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GregSL who wrote (8325)	1/17/1999 1:04:00 PM
From: aknahow	Read Replies (1) of 17367

Read your post and understand it. In fact I agree with it. But parsing my own words I do not believe I said the trial was being extended to reach a certain level of deaths but rather the trial was designed to stop when a certain level was reached. With that level it was felt statistical significance could be determined even if the total number of accruals was smaller than for most P III trials. Not reaching the level of deaths causes the trial to continue as planned from the start. This is not the same as extending a trial designed to stop when the number of subjects reached a certain level or a certain date was reached, for a new endpoint, total deaths.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next